- Comparison of Clinical Efficacy of Newfactan(R) versus Surfacten(R) for the Treatment of Respiratory Distress Syndrome in the Newborn Infants
-
Choi CW, Hwang JH, Yoo EJ, Kim KA, Koh SY, Lee YK, Shim JW, Lee EK, Chang W, Kim SS, Chang YS, Park WS, Shin SM
- KMID: 1712738
- J Korean Med Sci.
- 2005 Aug;20(4):591-597.
- doi: 10.3346/jkms.2005.20.4.591
Newfactan(R) is a domestically developed, bovine lung-derived, semi-synthetic surfactant. The aim of this study was to compare the clinical efficacy of Newfactan(R) with that of Surfacten(R) in the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Surfactant-TA, Calfactant and Poractant Alfa for Preterm Infants with Respiratory Distress Syndrome: A Retrospective Study
-
Jeon GW, Oh M, Sin JB
- KMID: 2070021
- Yonsei Med J.
- 2015 Mar;56(2):433-439.
- doi: 10.3349/ymj.2015.56.2.433
PURPOSE: To compare the efficacy of the new drug calfactant with the commonly used drugs surfactant-TA and poractant alfa. MATERIALS AND METHODS: A total of 332 preterm infants at 24-31 weeks'... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties
-
Bae CW, Chung SH, Choi YS
- KMID: 2466371
- Yonsei Med J.
- 2016 Jan;57(1):203-208.
- doi: 10.3349/ymj.2016.57.1.203
PURPOSE: Pulmonary surfactant (PS) replacement has been the gold standard therapy for neonatal respiratory distress syndrome; however, almost all commercial PSs contain animal proteins. We prepared a synthetic PS by... -
- CITED
-
- Close
- SHARE
-
- Close
